Patent Assignment
Reel/Frame 029946/0585
Assignment of Assignor's Interest
Recorded: 2013-03-07
Pages: 5
Assignors
BECKLOFF, MICHAEL C.
Executed: 2012-10-04
SEGRAVE, FRANK
Executed: 2012-10-01
MAURO, ROBERT
Executed: 2012-10-02
COLABUONO, PETER
Executed: 2012-10-03
Assignee
SILVERGATE PHARMACEUTICALS, INC.
5371 GORDON WAY, DUBLIN, OHIO, 43017
Covered Property
(1)
Enalapril Compositions
Patent:
8,568,747 →
Application:
13/670,355 →
Related Assignments
(15)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 7, 2013
From: RAJEWSKI, LIAN G.; RAJEWSKI, ROGER A.; HASLAM, JOHN L.; HEPPERT, KATHLEEN
To: UNIVERSITY OF KANSAS
Reel/Frame 029946/0416 →
Security Interest
Nov 3, 2015
From: SILVERGATE PHARMACEUTICALS, INC.
To: ESCALATE CAPITAL PARTNERS SBIC III, LP
Reel/Frame 036945/0861 →
Security Interest
Nov 23, 2015
From: SILVERGATE PHARMACEUTICALS, INC.
To: COMERICA BANK
Reel/Frame 037123/0437 →
Release of Security Interest
Dec 28, 2017
From: ESCALATE CAPITAL PARTNERS SBIC III, LP
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 044498/0193 →
Release of Security Interest
Dec 12, 2018
From: COMERICA BANK
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 047753/0443 →
Release of Security Interest
Dec 12, 2018
From: COMERICA BANK
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 047753/0401 →
Security Interest
Dec 19, 2018
From: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
To: WHITE OAK HEALTHCARE FINANCE, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 047815/0615 →
Release of Security Interest
May 17, 2019
From: WHITE OAK HEALTHCARE FINANCE, LLC, AS AGENT
To: ARGENTUM HOLDINGS, LLC; SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 049211/0188 →
Security Interest
May 17, 2019
From: CUTISPHARMA, INC.; SILVERGATE PHARMACEUTICALS, INC.
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 049209/0272 →
Security Interest
Apr 16, 2021
From: SILVERGATE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 055938/0895 →
Release of Security Interest
Aug 23, 2021
From: GOLDMAN SACHS BANK USA
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 057253/0348 →
Security Interest
Sep 20, 2021
From: SILVERGATE PHARMACEUTICALS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 057532/0550 →
Release of Security Interest
Sep 20, 2021
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: SILVERGATE PHARMACEUTICALS, INC.
Reel/Frame 057531/0556 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →
Confirmatory Grant of Security Interest in United States Patents
Mar 17, 2025
From: ARBOR PHARMACEUTICALS, LLC; AZURITY PHARMACEUTICALS, INC.; AZURITY PHARMACEUTICALS IRELAND LIMITED; SILVERGATE PHARMACEUTICALS, INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 070531/0487 →